DYAMTWVR* – SIL Dupilumab signature peptide qualifier
DYAMTWVR Stable Isotope Labeled Infliximab (DPL) peptide serves as a secondary internal standard to confirm DPL’s presence in biological samples by mass spectrometry.
SB-PEPTIDE’s Dupilumab SIL signature peptide qualifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. It is used in combination with Dupilumab SIL peptide quantifier,that is used as primary internal standard for DPL detection and quantification.
Technical specification
| Sequence : DYAMTWV-R*- [R*= R(13C/15N)] | |
| MW : 1 051.11 Da (C47H68N12O13S) | |
| Purity : > 95% | |
| Counter-Ion : TFA Salts (see option TFA removal) | |
| Delivery format : Freeze dried in propylene 2mL microtubes | |
| Other name : SIL DPL signature peptide qualifier | |
| Peptide Solubility Guideline | |
| Bulk peptide quantities available |
Price
| Catalog code | Size | Price € | Price $ USD |
| SB295-0.1MG | 0.1 mg | 385 | 481 |